foxa1在前列腺癌中的表达及临床相关性研究

《foxa1在前列腺癌中的表达及临床相关性研究》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、分类号R737.25UDC616.5密级公开硕士学位论文FOXA1在前列腺癌中的表达及临床相关性研究冯伟培养类别全日制学位类型学术学位一级学科(专业类)临床医学二级学科(专业)外科学（泌尿外科）研究方向泌尿系统肿瘤指导教师张红宾教授（主任医师）培养单位兰州军区总医院泌尿外科二O一五年五月第四军医大学硕士学位论文目录缩略语表·······························································································1中文摘要·······

2、························································································3英文摘要·······························································································5前言··············································································

3、·················8文献回顾······························································································10正文······························································································16第一部分FOXA1在前列腺癌中的表达及与肿瘤临床恶性程度的相关性········161材料········

4、····················································································162方法····························································································173结果···················································································

5、·········194讨论····························································································22第二部分FOXA1蛋白和mRNA表达在前列腺癌和前列腺增生中的意义·······271材料····························································································272方法···················

6、·········································································293结果····························································································344讨论····························································································37

7、小结······························································································40参考文献······························································································41个人简历和研究成果······························································

8、·················48致谢······························································································49